Sarepta Therapeutics Inc (SRPT)

04:24 AM

Sarepta stock plunges after ESSENCE trial misses primary endpoint By Investing.com - Investing.com Canada

04:24 AM

04:24 AM

Sarepta's Duchenne gene therapy misses main goal in study - Reuters

04:24 AM

04:20 AM

Earnings Flash (SRPT) Sarepta Therapeutics, Inc. Posts Q3 Adjusted Loss $0.13 per Share - MarketScreener

04:20 AM

04:05 AM

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

04:05 AM

07:55 AM

Is Sarepta Therapeutics Inc. stock supported by strong cash flows2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com

07:55 AM

06:50 AM

SRPT Crosses Above Average Analyst Target - Nasdaq

06:50 AM

06:21 AM

Forecasting Sarepta Therapeutics Inc. price range with options dataIPO Watch & Real-Time Chart Pattern Alerts - newser.com

06:21 AM

06:17 AM

What market sentiment indicators show for Sarepta Therapeutics Inc. (AB3A) stockQuarterly Performance Summary & Consistent Return Investment Signals - newser.com

06:17 AM

05:18 AM

Can Sarepta Therapeutics Inc. (AB3A) stock attract analyst upgrades2025 Support & Resistance & Weekly Momentum Picks - newser.com

05:18 AM

04:43 AM

Smart tools for monitoring Sarepta Therapeutics Inc.’s price action2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com

04:43 AM

04:24 AM

Will breakout in Sarepta Therapeutics Inc. lead to full recoveryGold Moves & Accurate Intraday Trade Tips - newser.com

04:24 AM

04:00 AM

Combining machine learning predictions for Sarepta Therapeutics Inc.July 2025 Trade Ideas & Stock Portfolio Risk Management - newser.com

04:00 AM

03:29 AM

State of New Jersey Common Pension Fund D Grows Stock Holdings in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

03:29 AM

02:16 AM

How Sarepta Therapeutics Inc. stock benefits from global expansionMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com

02:16 AM

01:45 AM

Relative strength of Sarepta Therapeutics Inc. in sector analysisQuarterly Profit Review & Community Verified Watchlist Alerts - newser.com

01:45 AM

12:58 PM

Is Sarepta Therapeutics Inc. (AB3A) stock testing key supportJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com

12:58 PM

12:07 PM

Analyzing drawdowns of Sarepta Therapeutics Inc. with statistical tools2025 Market Outlook & Weekly High Conviction Ideas - newser.com

12:07 PM

Nov 02, 2025

How Sarepta Therapeutics Inc. (AB3A) stock expands through international marketsJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

When is the best time to exit Sarepta Therapeutics Inc.Earnings Overview Summary & Low Volatility Stock Suggestions - newser.com

Nov 02, 2025

Nov 02, 2025

What technical charts say about Sarepta Therapeutics Inc. stockIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Is Sarepta Therapeutics Inc. trending in predictive chart models2025 Market Trends & Growth Focused Stock Pick Reports - newser.com

Nov 02, 2025

Nov 01, 2025

SAREPTA THERAPEUTICS Earnings Preview: Recent $SRPT Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Nov 01, 2025

Nov 01, 2025

What makes Sarepta Therapeutics Inc. (AB3A) stock appealing to growth investorsBear Alert & Weekly High Potential Stock Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $16.00 - MarketBeat

Oct 31, 2025

Oct 31, 2025

Is Sarepta Therapeutics Inc. stock attractive for passive investors2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com

Oct 31, 2025

Oct 31, 2025

What to do if you’re stuck in Sarepta Therapeutics Inc.Volume Spike & Free Risk Controlled Daily Trade Plans - newser.com

Oct 31, 2025

Oct 31, 2025

Is Sarepta Therapeutics Inc. stock ready for a breakoutJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com

Oct 31, 2025

Oct 31, 2025

Is Sarepta Therapeutics Inc. stock a good choice for value investors2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

Oct 31, 2025

Oct 31, 2025

Will Sarepta Therapeutics Inc. stock benefit from sector rotationJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Sarepta Therapeutics’ Long-term Study on SRP-9001: A Boost for Investor Confidence? - TipRanks

Oct 31, 2025

Oct 31, 2025

How to escape a deep drawdown in Sarepta Therapeutics Inc.2025 Winners & Losers & AI Driven Stock Reports - newser.com

Oct 31, 2025

Oct 30, 2025

Sarepta’s Gene Therapy Study: A Potential Game-Changer for Duchenne Muscular Dystrophy - TipRanks

Oct 30, 2025

Oct 30, 2025

Piper Sandler Maintains Sarepta Therapeutics (SRPT) Neutral Recommendation - Nasdaq

Oct 30, 2025

Oct 30, 2025

Interesting SRPT Put And Call Options For December 19th - Nasdaq

Oct 30, 2025

Oct 30, 2025

Piper Sandler Maintains Neutral Rating on SRPT, Raises Price Tar - GuruFocus

Oct 30, 2025

Oct 30, 2025

Sarepta Therapeutics (SRPT) to Release Quarterly Earnings on Monday - MarketBeat

Oct 30, 2025

Oct 29, 2025

Allianz Asset Management GmbH Has $252,000 Stock Holdings in Sarepta Therapeutics, Inc. $SRPT - MarketBeat

Oct 29, 2025